Whether it is a protein, vaccine or other molecules, the efficacy of the therapeutic agent needs to be demonstrated before each batch is released, which is usually done in cell-based assays. Cell-based assays are an important tool for drug discovery because they provide physiological data on the effects of drugs.
Creative Biolabs has long-standing experience in cell-based assays, including primary cells, transformed cell lines, and transfected reporter cell systems. The expertise of scientists in Creative Biolabs can characterize many different biological activities of your molecule, such as cell growth, cell death, induction of immune effector function, biomarker expression, induction or inhibition of signaling events, and drug internalization. Our experts work closely with you to provide a fully validated efficacy test for your biologics for regulatory submissions and can be reused throughout the drug development process.
Scientists in Creative Biolabs develop, validate and operate cell-based assays in a GLP regulatory environment to determine the safety and efficacy of biopharmaceuticals to support pre-clinical drug development. We use a range of cell-based analytical models to characterize recombinant proteins/monoclonal antibodies/vaccines (include but not limited to):
For more details, please feel free to contact us for project quotations and more detailed information.
All services and products are only for lab research use, not for any clinical diagnosis or treatment.
For any technical issues or products/services related questions, please leave your information below. Our team will contact you soon.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
Angiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE